Vaccinex, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-26.2M | $2.8M |
| FY2020 | $1.1M | $-26.6M | $10.6M |
| FY2021 | $175.0K | $7.4M | $8.6M |
| FY2022 | $101.0K | $5.2M | $6.4M |
| FY2023 | $26.0K | $-2.3M | $1.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-26.2M | $2.8M |
| FY2020 | $1.1M | $-26.6M | $10.6M |
| FY2021 | $175.0K | $7.4M | $8.6M |
| FY2022 | $101.0K | $5.2M | $6.4M |
| FY2023 | $26.0K | $-2.3M | $1.5M |